Agrippal

influenza vaccine (subunit)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Agrippal, covering 2006-11-01 to 2022-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months [Phase 3]